louisiana glp-1 gastric intestinal obstruction lawyer gastroparesis law firm in glp-1 gastroparesis law office in louisiana GLP-1 Drugs And Gastroparesis: What Patients Should Know? Attorney Jonathan Orent joins NewsNation
Description
GLP-1 analogs are often intentionally modified to improve pharmacokinetics, but unintended changes can impact product quality
Bioequivalence and Biosimilar Considerations As patents begin to expire, demonstrating bioequivalence or biosimilarity for GLP-1 therapies is a key focus
To the emerging Optimization Economy, it is brilliant product-market fit
Examples of DPP-4 drugs are sitagliptin (Januvia), alogliptin (Nesina), linagliptin (Tradjenta), and saxagliptin (Onglyza)
Slowing gastric emptying: Food stays in the stomach longer and is better absorbed as it moves more slowly through the intestines
